Dermata Therapeutics Ownership 2024 | Who Owns Dermata Therapeutics Now?
Institutional Ownership
38.16%
Insider Ownership
1.30%
Retail Ownership
60.54%
Institutional Holders
11.00
Dermata Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
RENAISSANCE TECHNOLOGIES LLC | 8.48% | - | 26,400 | 26,400 | 100.00% | 34,000 | Mar 31, 2023 |
TOWER RESEARCH CAPITAL LLC (TRC) | 1.87% | 0.00% | 5,808 | 5,808 | 100.00% | 7,000 | Mar 31, 2023 |
UBS GROUP AG | 1.11% | - | 3,445 | 3,445 | 100.00% | 4,444,000 | Mar 31, 2023 |
WELLS FARGO & COMPANY/MN | 0.49% | - | 1,526 | 1,526 | 100.00% | 1,969,000 | Mar 31, 2023 |
TWO SIGMA SECURITIES, LLC | - | - | - | -778 | -100.00% | - | Mar 31, 2023 |
WELLS FARGO & COMPANY/MN | - | - | - | -1,528 | -100.00% | - | Mar 31, 2023 |
TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -293 | -100.00% | - | Mar 31, 2023 |
GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -1,667 | -100.00% | - | Mar 31, 2023 |
SAGE CAPITAL ADVISORS,LLC | - | - | - | -750 | -100.00% | - | Mar 31, 2023 |
HC ADVISORS, LLC | - | - | - | -625 | -100.00% | - | Mar 31, 2023 |
RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC. | - | - | - | -8,861 | -100.00% | - | Mar 31, 2023 |
FAS WEALTH PARTNERS, INC. | - | - | - | -794 | -100.00% | - | Mar 31, 2023 |
TUDOR INVESTMENT CORP ET AL | - | - | - | -638 | -100.00% | - | Mar 31, 2023 |
MORGAN STANLEY | - | - | - | -36 | -100.00% | - | Mar 31, 2023 |
UBS GROUP AG | - | - | - | -2,332 | -100.00% | - | Mar 31, 2023 |
Dermata Therapeutics's largest institutional shareholder is RENAISSANCE TECHNOLOGIES LLC, holding 8.48% of the company's total share outstanding, currently valued at $34.00K. The top 10 institutional shareholders own together 11.94% of the company.
Institutional Shareholders by % of Total Assets
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
TOWER RESEARCH CAPITAL LLC (TRC) | 1.87% | 0.00% | 5,808 | 5,808 | 100.00% | 7,000 | Mar 31, 2023 |
RENAISSANCE TECHNOLOGIES LLC | 8.48% | - | 26,400 | 26,400 | 100.00% | 34,000 | Mar 31, 2023 |
UBS GROUP AG | 1.11% | - | 3,445 | 3,445 | 100.00% | 4,444,000 | Mar 31, 2023 |
WELLS FARGO & COMPANY/MN | 0.49% | - | 1,526 | 1,526 | 100.00% | 1,969,000 | Mar 31, 2023 |
TWO SIGMA SECURITIES, LLC | - | - | - | -778 | -100.00% | - | Mar 31, 2023 |
WELLS FARGO & COMPANY/MN | - | - | - | -1,528 | -100.00% | - | Mar 31, 2023 |
TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -293 | -100.00% | - | Mar 31, 2023 |
GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -1,667 | -100.00% | - | Mar 31, 2023 |
SAGE CAPITAL ADVISORS,LLC | - | - | - | -750 | -100.00% | - | Mar 31, 2023 |
HC ADVISORS, LLC | - | - | - | -625 | -100.00% | - | Mar 31, 2023 |
RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC. | - | - | - | -8,861 | -100.00% | - | Mar 31, 2023 |
FAS WEALTH PARTNERS, INC. | - | - | - | -794 | -100.00% | - | Mar 31, 2023 |
TUDOR INVESTMENT CORP ET AL | - | - | - | -638 | -100.00% | - | Mar 31, 2023 |
MORGAN STANLEY | - | - | - | -36 | -100.00% | - | Mar 31, 2023 |
UBS GROUP AG | - | - | - | -2,332 | -100.00% | - | Mar 31, 2023 |
The largest Dermata Therapeutics shareholder by % of total assets is TOWER RESEARCH CAPITAL LLC (TRC). The company owns 5.81K shares of Dermata Therapeutics (DRMA), representing 0.00% of its total assets.
Institutional Buyers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
RENAISSANCE TECHNOLOGIES LLC | 8.48% | - | 26,400 | 26,400 | 100.00% | 34,000 | Mar 31, 2023 |
TOWER RESEARCH CAPITAL LLC (TRC) | 1.87% | 0.00% | 5,808 | 5,808 | 100.00% | 7,000 | Mar 31, 2023 |
UBS GROUP AG | 1.11% | - | 3,445 | 3,445 | 100.00% | 4,444,000 | Mar 31, 2023 |
WELLS FARGO & COMPANY/MN | 0.49% | - | 1,526 | 1,526 | 100.00% | 1,969,000 | Mar 31, 2023 |
MORGAN STANLEY | - | - | - | -36 | -100.00% | - | Mar 31, 2023 |
TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -293 | -100.00% | - | Mar 31, 2023 |
HC ADVISORS, LLC | - | - | - | -625 | -100.00% | - | Mar 31, 2023 |
TUDOR INVESTMENT CORP ET AL | - | - | - | -638 | -100.00% | - | Mar 31, 2023 |
SAGE CAPITAL ADVISORS,LLC | - | - | - | -750 | -100.00% | - | Mar 31, 2023 |
TWO SIGMA SECURITIES, LLC | - | - | - | -778 | -100.00% | - | Mar 31, 2023 |
FAS WEALTH PARTNERS, INC. | - | - | - | -794 | -100.00% | - | Mar 31, 2023 |
WELLS FARGO & COMPANY/MN | - | - | - | -1,528 | -100.00% | - | Mar 31, 2023 |
GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -1,667 | -100.00% | - | Mar 31, 2023 |
UBS GROUP AG | - | - | - | -2,332 | -100.00% | - | Mar 31, 2023 |
RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC. | - | - | - | -8,861 | -100.00% | - | Mar 31, 2023 |
As of Mar 31 2023, Dermata Therapeutics's largest institutional buyer is RENAISSANCE TECHNOLOGIES LLC. The company purchased 26.40K stocks of DRMA, valued at $34.00K.
Institutional Sellers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC. | - | - | - | -8,861 | -100.00% | - | Mar 31, 2023 |
UBS GROUP AG | - | - | - | -2,332 | -100.00% | - | Mar 31, 2023 |
GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -1,667 | -100.00% | - | Mar 31, 2023 |
WELLS FARGO & COMPANY/MN | - | - | - | -1,528 | -100.00% | - | Mar 31, 2023 |
FAS WEALTH PARTNERS, INC. | - | - | - | -794 | -100.00% | - | Mar 31, 2023 |
TWO SIGMA SECURITIES, LLC | - | - | - | -778 | -100.00% | - | Mar 31, 2023 |
SAGE CAPITAL ADVISORS,LLC | - | - | - | -750 | -100.00% | - | Mar 31, 2023 |
TUDOR INVESTMENT CORP ET AL | - | - | - | -638 | -100.00% | - | Mar 31, 2023 |
HC ADVISORS, LLC | - | - | - | -625 | -100.00% | - | Mar 31, 2023 |
TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -293 | -100.00% | - | Mar 31, 2023 |
MORGAN STANLEY | - | - | - | -36 | -100.00% | - | Mar 31, 2023 |
WELLS FARGO & COMPANY/MN | 0.49% | - | 1,526 | 1,526 | 100.00% | 1,969,000 | Mar 31, 2023 |
UBS GROUP AG | 1.11% | - | 3,445 | 3,445 | 100.00% | 4,444,000 | Mar 31, 2023 |
TOWER RESEARCH CAPITAL LLC (TRC) | 1.87% | 0.00% | 5,808 | 5,808 | 100.00% | 7,000 | Mar 31, 2023 |
RENAISSANCE TECHNOLOGIES LLC | 8.48% | - | 26,400 | 26,400 | 100.00% | 34,000 | Mar 31, 2023 |
As of Mar 31 2023, Dermata Therapeutics's biggest institutional seller is RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC.. The company sold -8.86K shares of DRMA, valued at -.
Institutional New positions
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
RENAISSANCE TECHNOLOGIES LLC | 8.48% | - | 26,400 | 26,400 | 100.00% | 34,000 | Mar 31, 2023 |
TOWER RESEARCH CAPITAL LLC (TRC) | 1.87% | 0.00% | 5,808 | 5,808 | 100.00% | 7,000 | Mar 31, 2023 |
UBS GROUP AG | 1.11% | - | 3,445 | 3,445 | 100.00% | 4,444,000 | Mar 31, 2023 |
WELLS FARGO & COMPANY/MN | 0.49% | - | 1,526 | 1,526 | 100.00% | 1,969,000 | Mar 31, 2023 |
Dermata Therapeutics's largest new institutional shareholder by number of shares is RENAISSANCE TECHNOLOGIES LLC, purchased 26.40K shares, valued at $34.00K, as of undefined.
Institutional Sold Out
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC. | - | - | - | -8,861 | -100.00% | - | Mar 31, 2023 |
UBS GROUP AG | - | - | - | -2,332 | -100.00% | - | Mar 31, 2023 |
GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -1,667 | -100.00% | - | Mar 31, 2023 |
WELLS FARGO & COMPANY/MN | - | - | - | -1,528 | -100.00% | - | Mar 31, 2023 |
FAS WEALTH PARTNERS, INC. | - | - | - | -794 | -100.00% | - | Mar 31, 2023 |
TWO SIGMA SECURITIES, LLC | - | - | - | -778 | -100.00% | - | Mar 31, 2023 |
SAGE CAPITAL ADVISORS,LLC | - | - | - | -750 | -100.00% | - | Mar 31, 2023 |
TUDOR INVESTMENT CORP ET AL | - | - | - | -638 | -100.00% | - | Mar 31, 2023 |
HC ADVISORS, LLC | - | - | - | -625 | -100.00% | - | Mar 31, 2023 |
TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -293 | -100.00% | - | Mar 31, 2023 |
MORGAN STANLEY | - | - | - | -36 | -100.00% | - | Mar 31, 2023 |
Dermata Therapeutics's largest sold out institutional shareholder by shares sold is RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC., sold -8.86K shares, valued at -, as of undefined.
Dermata Therapeutics Mutual Fund Holders
Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
---|---|---|---|---|---|
FIDELITY CONCORD STREET TRUST | 0.00% | 26,629 | - | - | Feb 29, 2024 |
FIDELITY CONCORD STREET TRUST | 0.00% | 12,237 | - | - | Feb 29, 2024 |
VANGUARD INDEX FUNDS | 0.00% | 1,718 | - | - | Mar 31, 2024 |
iSHARES TRUST | 0.00% | 17,157 | - | - | Mar 31, 2024 |
EQ ADVISORS TRUST | 0.00% | 512 | - | - | Mar 31, 2024 |
Dermata Therapeutics's largest mutual fund holder by % of total assets is "FIDELITY CONCORD STREET TRUST", owning 26.63K shares, compromising 0.00% of its total assets.
Dermata Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
Date | Holdings | Change % |
---|---|---|
31 Dec, 22 | 11 | 22.22% |
30 Sep, 22 | 9 | -10.00% |
30 Jun, 22 | 10 | 42.86% |
31 Mar, 22 | 7 | -30.00% |
31 Dec, 21 | 10 | 25.00% |
30 Sep, 21 | 8 | - |
As of 31 Dec 22, 11 institutions are holding Dermata Therapeutics's shares, representing an increase of 22.22% compared to the previous quarter.
Shares Outstanding Trend
Date | Shares Outstanding | Change % |
---|---|---|
31 Dec, 22 | 292,762 | 48.44% |
30 Sep, 22 | 197,232 | -76.89% |
30 Jun, 22 | 853,449 | 1074.14% |
31 Mar, 22 | 72,687 | -44.17% |
31 Dec, 21 | 130,204 | -50.67% |
30 Sep, 21 | 263,947 | - |
Dermata Therapeutics (DRMA) has 292.76K shares outstanding as of 31 Dec 22, up 48.44% compared to the previous quarter.
Institutional Ownership Trend
Date | Ownership % | Change % |
---|---|---|
31 Dec, 22 | 38.16% | 5.77% |
30 Sep, 22 | 25.71% | 0.17% |
30 Jun, 22 | 121.98% | 62.91% |
31 Mar, 22 | 13.92% | 0.59% |
31 Dec, 21 | 48.42% | 0.50% |
30 Sep, 21 | 98.16% | - |
As of 31 Dec 22, Dermata Therapeutics is held by 38.16% institutional shareholders, representing a 5.77% growth compared to 30 Sep 22.
Institutional Increased Positions Trend
Date | Increased Positions | Change % |
---|---|---|
31 Dec, 22 | 7 | 40.00% |
30 Sep, 22 | 5 | -37.50% |
30 Jun, 22 | 8 | 100.00% |
31 Mar, 22 | 4 | -55.56% |
31 Dec, 21 | 9 | 28.57% |
30 Sep, 21 | 7 | - |
7 institutional shareholders have increased their position in DRMA stock as of 31 Dec 22 compared to 5 in the previous quarter (a 40.00% increase).
Institutional Reduced Positions Trend
Date | Reduced Positions | Change % |
---|---|---|
31 Dec, 22 | 1 | - |
30 Sep, 22 | 1 | - |
30 Jun, 22 | - | -100.00% |
31 Mar, 22 | 1 | - |
31 Dec, 21 | 1 | - |
30 Sep, 21 | - | - |
1 institutional shareholders have reduced their position in DRMA stock as of 31 Dec 22 compared to 1 in the previous quarter (a 0.00% increase).
All Institutional Ownership Trend Data
Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
---|---|---|---|---|---|---|---|---|---|---|
31 Dec, 22 | 11 | 22.22% | 292,762 | 48.44% | 38.16% | 5.77% | 7 | 40.00% | 1 | - |
30 Sep, 22 | 9 | -10.00% | 197,232 | -76.89% | 25.71% | 0.17% | 5 | -37.50% | 1 | - |
30 Jun, 22 | 10 | 42.86% | 853,449 | 1074.14% | 121.98% | 62.91% | 8 | 100.00% | - | -100.00% |
31 Mar, 22 | 7 | -30.00% | 72,687 | -44.17% | 13.92% | 0.59% | 4 | -55.56% | 1 | - |
31 Dec, 21 | 10 | 25.00% | 130,204 | -50.67% | 48.42% | 0.50% | 9 | 28.57% | 1 | - |
30 Sep, 21 | 8 | - | 263,947 | - | 98.16% | - | 7 | - | - | - |
Dermata Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
---|
Open Market Insider Buys
Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
---|
Insider Sells
Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
---|
All Insider Owners Trades
Dermata Therapeutics Insider Ownership Trends
All Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q1 2024 | 11 | - | - |
Q1 2023 | 3 | - | - |
Q4 2022 | 6 | - | - |
Q3 2022 | 7 | - | - |
Q2 2022 | 6 | - | - |
Q3 2021 | 39 | 15 | 260.00% |
11 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Dermata Therapeutics's insiders, as of Q1 2024.
Open Market Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q1 2024 | - | - | - |
Q1 2023 | - | - | - |
Q4 2022 | - | - | - |
Q3 2022 | - | - | - |
Q2 2022 | - | - | - |
Q3 2021 | 4 | - | - |
As of Q1 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Dermata Therapeutics's stocks.
Dermata Therapeutics Peer Ownership
Ticker | Company |
---|---|
ZVSA | ZyVersa Therapeutics, Inc. |
ENSC | Ensysce Biosciences, Inc. |
PHIO | Phio Pharmaceuticals Corp. |
REVB | Revelation Biosciences, Inc. |
AVRO | AVROBIO, Inc. |
EFTR | eFFECTOR Therapeutics, Inc. |
IMMX | Immix Biopharma, Inc. |
CYTO | Altamira Therapeutics Ltd. |
SONN | Sonnet BioTherapeutics Holdings, Inc. |
WINT | Windtree Therapeutics, Inc. |
HEPA | Hepion Pharmaceuticals, Inc. |
BXRX | Baudax Bio, Inc. |
ZURA | Zura Bio Limited |
CDIO | Cardio Diagnostics Holdings, Inc. |
ATNF | 180 Life Sciences Corp. |
DRMA Ownership FAQ
Who Owns Dermata Therapeutics?
Dermata Therapeutics is owned by institutional shareholders (38.16%), insiders (1.30%), and public (60.54%). The largest institutional shareholder of Dermata Therapeutics is RENAISSANCE TECHNOLOGIES LLC (8.48% of total shares) and the top mutual fund owner is FIDELITY CONCORD STREET TRUST (0.00% of total shares).
Who are the major institutional shareholders of Dermata Therapeutics?
Dermata Therapeutics's major institutional shareholders are RENAISSANCE TECHNOLOGIES LLC, TOWER RESEARCH CAPITAL LLC (TRC), UBS GROUP AG, WELLS FARGO & COMPANY/MN, and TWO SIGMA SECURITIES, LLC. The top five shareholders own together 11.94% of the company's share outstanding.
How many Dermata Therapeutics shareholders are there?
As of Dec 2022, there are 11 institutional shareholders of Dermata Therapeutics.
What percentage of Dermata Therapeutics is owned by RENAISSANCE TECHNOLOGIES LLC?
RENAISSANCE TECHNOLOGIES LLC owns 26.4K shares of Dermata Therapeutics, representing 8.48% of the company's total shares outstanding, valued at $34K (as of Mar 2023).
What percentage of Dermata Therapeutics is owned by TOWER RESEARCH CAPITAL LLC (TRC)?
As of Mar 2023, TOWER RESEARCH CAPITAL LLC (TRC) holds 5.81K shares of Dermata Therapeutics (DRMA), compromising 1.87% of the company, valued at $7K.
What percentage of Dermata Therapeutics is owned by UBS GROUP AG?
UBS GROUP AG is the third largest holder of Dermata Therapeutics. The company owns 3.44K of the company's shares outstanding (worth $4.44M).